Table 1.
Cancer type/control group | Sample size (N) | Age at diagnosis (Mean ± SD) | Male (%) |
---|---|---|---|
Bladder | 343 | 69 ± 10 | 74.34% |
Breast | 827 | 60 ± 13 | 0.00% |
Colorectal | 387 | 68 ± 13 | 52.97% |
Glioma | 992 | 52 ± 16 | 58.76% |
Lung | 908 | 67 ± 9 | 60.90% |
Melanoma | 450 | 59 ± 16 | 61.78% |
Ovarian | 531 | 60 ± 12 | 0.00% |
Pancreatic | 163 | 66 ± 11 | 55.21% |
Prostate | 421 | 62 ± 7 | 100.00% |
Renal | 453 | 62 ± 12 | 67.11% |
Thyroid | 387 | 49 ± 16 | 27.39% |
eMERGE | 13 427 | – | 47.72% |